Maximum Dose of Olanzapine IM
The maximum single dose of intramuscular olanzapine is 10 mg per injection, with a maximum total daily dose of 30 mg (typically administered as three 10 mg injections spaced 2-4 hours apart). 1
Dosing Parameters
The FDA-approved dosing for IM olanzapine in acute agitation follows these specific limits:
- Recommended single dose: 10 mg IM
- Lower doses available: 5 mg or 7.5 mg may be considered based on clinical factors
- Maximum daily dose: 30 mg total
- Minimum interval between doses: 2 hours after the first dose, then 4 hours after the second dose
- Maximum frequency: Three injections per 24-hour period 1
Critical Safety Considerations
Maximal dosing (three 10 mg injections at 2-4 hour intervals) carries substantial risk for orthostatic hypotension. The FDA label explicitly states that patients requiring subsequent injections must be assessed for orthostatic hypotension before each additional dose. Administration to patients with clinically significant postural blood pressure changes is not recommended 1.
Evidence Base
The dose-response relationship for IM olanzapine was established in controlled trials showing efficacy across 2.5-10 mg doses, with 10 mg demonstrating the greatest reduction in agitation scores (mean PANSS-EC reduction of -9.4 at 2 hours) 2. Clinical trials specifically evaluated the safety of repeated dosing but did not systematically assess doses exceeding 30 mg daily or injections given more frequently than the 2-4 hour intervals 1.
In comparative effectiveness studies, olanzapine 10 mg IM demonstrated superior sedation compared to haloperidol and ziprasidone, though midazolam achieved faster sedation at 15 minutes 3.
Special Population Adjustments
Reduce the dose in these circumstances:
- Geriatric patients: 5 mg per injection 1
- Debilitated patients: 2.5 mg per injection 1
- Predisposition to hypotension: 2.5 mg per injection 1
- Pharmacodynamic sensitivity: 2.5 mg per injection 1
Transition to Oral Therapy
Once agitation is controlled, transition to oral olanzapine (5-20 mg daily) as soon as clinically appropriate. The IM formulation is intended only for acute management, not maintenance therapy 1.
Common Pitfall
Do not exceed 30 mg total daily dose or administer injections more frequently than specified intervals. These limits exist because safety data beyond these parameters are lacking, and the risk of orthostatic hypotension increases substantially with maximal dosing 1.